No Detail Found!

Frequency of side Effects of Sofosbuvir and Daclatasvir in Patients of Chronic Hepatitis C

Author(s)
Khawaja Tahir Maqbool Jinnah Hospital, Lahore, Pakistan.
Sahrish Rashid Jinnah Hospital Lahore, Pakistan.
Arslan Shahzad Fazaia Medical College, Islamabad, Pakistan.
Sidra Rafique Jinnah Hospital Lahore, Pakistan.
Abstract
Background: Hepatitis is a common problem in Pakistan. Pakistan is the second most prevalent country regarding hepatitis C with a prevalence rate of 6.7%. Genotype 3 is the most commonly detected genotype in Pakistan. This study was conducting in Hepatitis Clinic, Medical Unit II, Jinnah Hospital Lahore and study duration was three months starting from 1st Dec 2018 to 28th Feb 2019. In our study we evaluate side effects of direct acting antivirals for hepatitis C patients by using descriptive case series. Methods: Forty patients meeting the inclusion criteria were included in the study. All patients were then given direct anti-virals for a period of three months. Patients were called after every four weeks and observed for the presence of side effects like fever, fatigue, malaise, generalized weakness, myalgia, nausea and vomiting. Data was entered and analyzed in SPSS version ver.21.0. Frequency and percentages were calculated for demographic and clinical profile and side effects. Mean and Standard deviation was calculated for biochemical values at base line and end of therapy. Chi-square test was used to assess side effects among age, gender and duration of disease and paired t test for biochemical parameters with p .05). There was a statistically significant difference between mean baseline and at end treatment values for AST, ALT, AP and TLC. ( P< .05). Conclusion: Our study concluded that along with efficacy advantage of DAA therapy, their safety profile is acceptable in terms of adverse drug reaction of immediate or during treatment however long term follow up is needed to ascertain and apprehend the safety matters linked with the utilization of DAAs.
Publication Details
Page(s) 138-142
DOI DOI not available
Published Journal: Journal of Rawalpindi Medical College, Volume: 23, Issue: 3, Year: 2019

Request the full text from PASTIC

Keywords
side effects, Chronic Hepatitis C., Direct Acting Antivirals (DAAs)
0

Citations

0

Downloads

124

Views